diabetes drug was pulled from the market in France on Thursday due to
perceived bladder cancer risk, said U.S. regulators have not signaled any
intention to request a recall of the blockbuster product.
Source: http://news.feedzilla.com/en_us/stories/society/environment/99697888?client_source=feed&format=rss

No comments:
Post a Comment